Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR phosphorylate PLCG1

Class:IdReaction:9665411
_displayNamePhosphorylated heterodimers of ERBB2 ECD mutants and EGFR phosphorylate PLCG1
_doReleaseTRUE
_timestamp2020-02-13 21:17:14
authored[InstanceEdit:9665241] Orlic-Milacic, Marija, 2019-10-30
catalystActivity[CatalystActivity:9665459] protein tyrosine kinase activity of p-6Y-ERBB2 ECD mutants:EGF:p-6Y-EGFR:PLCG1 [plasma membrane]
compartment[Compartment:70101] cytosol
[Compartment:876] plasma membrane
created[InstanceEdit:9665414] Orlic-Milacic, Marija, 2019-10-30
disease[Disease:1500689] cancer
edited[InstanceEdit:9665760] Orlic-Milacic, Marija, 2019-11-01
entityFunctionalStatus[EntityFunctionalStatus:9665462] gain_of_function of p-6Y-ERBB2 ECD mutants:EGF:p-6Y-EGFR:PLCG1 [plasma membrane]
input[Complex:9665460] p-6Y-ERBB2 ECD mutants:EGF:p-6Y-EGFR:PLCG1 [plasma membrane] [Homo sapiens]
[SimpleEntity:113592] ATP [cytosol]
[SimpleEntity:113592] ATP [cytosol]
[SimpleEntity:113592] ATP [cytosol]
[SimpleEntity:113592] ATP [cytosol]
isChimericFALSE
literatureReference[LiteratureReference:9646435] Activating HER2 mutations in HER2 gene amplification negative breast cancer
[LiteratureReference:9665365] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
modified[InstanceEdit:9665432] Orlic-Milacic, Marija, 2019-10-30
[InstanceEdit:9665465] Orlic-Milacic, Marija, 2019-10-31
[InstanceEdit:9665478] Orlic-Milacic, Marija, 2019-10-31
[InstanceEdit:9665494] Orlic-Milacic, Marija, 2019-10-31
[InstanceEdit:9665496] Orlic-Milacic, Marija, 2019-10-31
[InstanceEdit:9666039] Orlic-Milacic, Marija, 2019-11-01
[InstanceEdit:9666040] Orlic-Milacic, Marija, 2019-11-01
[InstanceEdit:9666041] Orlic-Milacic, Marija, 2019-11-01
[InstanceEdit:9666042] Orlic-Milacic, Marija, 2019-11-01
[InstanceEdit:9666742] Orlic-Milacic, Marija, 2019-11-06
[InstanceEdit:9667512] Orlic-Milacic, Marija, 2019-11-12
[InstanceEdit:9676412] Orlic-Milacic, Marija, 2020-02-13
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
namePhosphorylated heterodimers of ERBB2 ECD mutants and EGFR phosphorylate PLCG1
normalReaction
output[EntityWithAccessionedSequence:167679] p-4Y-PLCG1 [plasma membrane] [Homo sapiens]
[Complex:9665380] p-6Y-ERBB2 ECD mutants:EGF:p-6Y-EGFR [plasma membrane] [Homo sapiens]
[SimpleEntity:29370] ADP [cytosol]
[SimpleEntity:29370] ADP [cytosol]
[SimpleEntity:29370] ADP [cytosol]
[SimpleEntity:29370] ADP [cytosol]
precedingEvent
releaseDate2020-03-17
reviewed[InstanceEdit:9666036] Bose, Ron, 2019-10-25
[InstanceEdit:9666034] Krishna, Anagha, 2019-10-25
[InstanceEdit:9666741] Kancha, Rama Krishna, 2019-11-03
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9665424] R-HSA-9665411.2
summation[Summation:9665488] PLCgamma1 signaling is activated dowsntream of ERBB2 ECD mut...
(hasEvent)[Pathway:9665348] Signaling by ERBB2 ECD mutants [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR phosphorylate PLCG1 (9665411)